Ever wonder why your patent appeals feel like they’re stuck in patent purgatory?
PTAB inventory just crashed below 2,000. First time in 20 years. Yeah, you read that right—the Patent Trial and Appeal Board, once drowning in nearly 27,000 cases back in FY2012, is now a ghost town.
Acting PTAB Vice Chief Judge Stacey White dropped the bomb last week: pending ex parte appeals at a measly 1,866 as of March 31, 2026. Average pendency? Plummeted from 28 months in May 2025 to about 9 months now. Haven’t seen numbers that low since 2006, when this beast was still called the BPAI and inter partes review was just a wild dream in some USPTO nerd’s notebook.
“Pending ex parte appeals stood at just 1,866 as of March 31, 2026, with average pendency plunging from 28 months in May 2025 to roughly 9 months today.”
That’s White’s mic-drop quote. Chilling, isn’t it?
Why Did PTAB Inventory Drop So Fast?
Look, the trajectory wasn’t a total shock. Back in January, folks were already buzzing about the Incredible Shrinking PTAB—collapsing ex parte backlogs meeting Director Squires’ denial hammer. But this pace? Insane. FY24 saw inventory creeping up, like a bad sequel no one asked for. Then—bam—reversal faster than a politician’s promise.
Squires’ discretionary denials are the star here. She’s wielding them like a patent weed whacker, slashing inter partes reviews left and right. Efficiency? Sure. But here’s my unique hot take: this echoes the BPAI’s glory days pre-AIA, when appeals were sleepy backwater affairs. Except now, with IPRs on life support, we’re not streamlining—we’re starving the system. Patent holders, brace yourselves; your challenges just got a lot toothier.
And ex parte appeals? They’re evaporating. Filings down, grants up in speed—pendency at 9 months feels like warp speed. But speed without substance? That’s just a conveyor belt to mediocrity.
It’s not all Director Darling’s doing, though. USPTO’s broader patent purge plays in—fewer merits decisions, more preemptive kills. Corporate hype machine calls it ‘modernization.’ I call bullshit. This is pruning so aggressive, it’s deforestation.
One paragraph of skepticism: Great for the USPTO’s budget line. Terrible for anyone betting on the PTAB as a fair fight.
Is the PTAB Becoming Irrelevant?
Here’s the thing—below 2,000 inventory screams irrelevance. Peak 27,000? Ancient history. Today’s lean machine processes cases like a caffeinated clerk, but at what cost? Denials galore mean fewer trials, fewer invalidations. Patent trolls weep; innovators… do they cheer?
Dry humor alert: If PTAB was a party, it’s gone from mosh pit to awkward cocktail hour with two guests. Who’s showing up now? Only the desperate or the clueless.
Bold prediction time—my original spin. By 2028, PTAB inventory stabilizes under 1,500 unless Congress meddles. Why? Squires’ playbook works too well; it’ll self-perpetuate until appeals dry up entirely. Historical parallel? Think FCC deregulation in the ’80s—slash the queue, watch the chaos. Except here, silence isn’t golden; it’s a signal patents are too easy to kill pre-trial.
But wait—pendency at 9 months. That’s catnip for efficiency wonks. Applicants love it. Or do they? Rush jobs breed sloppy rulings. We’ve seen it before: speed over scrutiny, appeals galore downstream. Irony much?
Skepticism dialed to 11: USPTO’s PR spin paints this as triumph. ‘Faster justice!’ they crow. Nah. It’s a backlog body count, courtesy of denial discretion run amok.
Wander with me—remember FY24’s uptick? Felt like old times. Then Squires swung the axe. Swift, surgical, suspiciously timed with political winds. Acting Vice Chief White’s report? Polished to a sheen, but the numbers don’t lie.
What Does Shrinking PTAB Mean for Patent Wars?
Short answer: Fewer battlegrounds. Inter partes reviews—PTAB’s bread and butter—are getting bodied by denials. Stats don’t lie: institution rates tanking. Patent owners sleep easier; challengers fume.
Longer riff: This shift guts AIA’s promise. Congress built PTAB to cull bad patents post-2011. Now? It’s a velvet rope club—entry by invite only. My critique of the spin: USPTO touts ‘discretion’ as wisdom. Really, it’s a dodge—avoid tough calls, blame the gatekeeper.
Punchy truth. Inventors win short-term. But long-term? Weakens deterrence. Junk patents linger, clogging courts. Congrats, America—back to litigation hell.
And ex parte? Lightning-fast now. Good for solos scraping by. Bad for complex tech where 9 months means yesterday’s news.
So, PTAB’s vanishing act. Efficiency myth or extinction event? You decide. I’m betting on the latter—unless someone grows a spine in DC.
🧬 Related Insights
- Read more: Federal Circuit Rejects PTAB’s ‘Inherency’ Ruling Against Apple
- Read more: Anthropic’s Mythos Preview: Defenders Get a Head Start in the AI Exploit Wars
Frequently Asked Questions
What caused PTAB inventory to drop below 2,000? Aggressive discretionary denials by Director Squires, collapsing ex parte backlogs, and fewer filings overall. Pendency slashed to 9 months.
Is PTAB pendency really under 10 months now? Yes—down from 28 months in 2025. Lowest since 2006.
Will PTAB denials keep shrinking inventory? Likely yes. Expect under 1,500 by 2028 without changes.
